Publications
484 publications
Sort by:
- Date
- Relevance
-
Rimonabant (Acomplia) for the indication 'obesity'
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
-
Ibandronate i.v. [3 mg-3 ml] (Bonviva) for the indication 'postmenopausal osteoporosis'
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
-
Rituximab (Mabthera) for the indication 'maintenance treatment of follicular lymphoma'
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
-
Erlotinib (Tarceva)
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.